Butanoic acid, 2-amino-4-(methylsulfinyl)-

Suppliers

Names

[ CAS No. ]:
454-41-1

[ Name ]:
Butanoic acid, 2-amino-4-(methylsulfinyl)-

[Synonym ]:
METHIONINE SULFOXIDE,DL
DL-METHIONINE-DL-SULFOXIDE
EINECS 263-700-7
METHIONINESULPHOXIDE
H-DL-MET(O)-OH
MFCD00002620
(S)-Methionin-(S)-sulfoxid
methionine (S)-sulfoxide
DL-METHIONINE SULPHOXIDE

Chemical & Physical Properties

[ Melting Point ]:
-240ºC (dec.)

[ Molecular Formula ]:
C5H11NO3S

[ Molecular Weight ]:
165.21100

[ Exact Mass ]:
165.04600

[ PSA ]:
99.60000

[ LogP ]:
0.73290

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
ES7120000
CHEMICAL NAME :
Butyric acid, 2-amino-4-(methylsulfinyl)-
CAS REGISTRY NUMBER :
454-41-1
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C5-H11-N-O3-S
MOLECULAR WEIGHT :
165.23
WISWESSER LINE NOTATION :
QVYZ2SO&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IJRBA3 International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine. (Taylor & Francis Inc., 242 Cherry St., Philadelphia, PA 19106) V.1- 1959- Volume(issue)/page/year: 3,41,1961 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
3500 mg/kg
SEX/DURATION :
female 9-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
ASMUAA Acta Scholae Medicinalis Universitatis in Kioto. (Kyoto, Japan) V.27-40, 1947-70. Discontinued. Volume(issue)/page/year: 38,193,1962

Safety Information

[ Hazard Codes ]:
Xn

[ WGK Germany ]:
3

[ RTECS ]:
ES7120000

Related Compounds

  • Butanoic acid, 2-amino-4-(methylsulfinyl)-
  • Butanoic acid, 2-amino-4-(methylsulfinyl)-
  • Butanoic acid, 2-amino-4-(methylsulfinyl)-
  • Butanoic acid, 2-amino-4-(methylsulfinyl)-, (2R)-
  • Butanoic acid, 2-amino-4-(methylsulfinyl)-, (R*,S*)- (9CI)
  • Butanoic acid, 2-amino-4-(S-methylsulfinimidoyl)-, (2S)- (9CI)
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 3-chloro-N-(4-((4-(3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl)-1H-imidazol-1-yl)methyl)phenyl)benzenesulfonamide
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide